Reduction of hepatitis B surface antigen levels and hepatitis B surface antigen seroclearance in chronic hepatitis B patients receiving 10 years of nucleoside analogue therapy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reduction of hepatitis B surface antigen levels and hepatitis B surface antigen seroclearance in chronic hepatitis B patients receiving 10 years of nucleoside analogue therapy
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 58, Issue 3, Pages 923-931
Publisher
Wiley
Online
2013-03-07
DOI
10.1002/hep.26376
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reduction of Hepatitis B Surface Antigen and Covalently Closed Circular DNA by Nucleos(t)ide Analogues of Different Potency
- (2013) Danny Ka-Ho Wong et al. Clinical Gastroenterology and Hepatology
- HLA-DP and IL28B Polymorphisms: Influence of Host Genome on Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B
- (2013) Wai-Kay Seto et al. CLINICAL INFECTIOUS DISEASES
- High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load
- (2012) Tai–Chung Tseng et al. GASTROENTEROLOGY
- IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B
- (2012) Pietro Lampertico et al. HEPATOLOGY
- A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance
- (2012) Wai-Kay Seto et al. HEPATOLOGY
- Serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B
- (2012) Wai-Kay Seto et al. Hepatology International
- Future Prevention and Treatment of Chronic Hepatitis B Infection
- (2012) Wai-Kay Seto et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5years
- (2012) Massimo Fasano et al. JOURNAL OF HEPATOLOGY
- High Hepatitis B Surface Antigen Levels Predict Insignificant Fibrosis in Hepatitis B e Antigen Positive Chronic Hepatitis B
- (2012) Wai-Kay Seto et al. PLoS One
- Three Years of Continuous Entecavir Therapy in Treatment-Naïve Chronic Hepatitis B Patients: VIRAL Suppression, Viral Resistance and Clinical Safety
- (2011) Man-Fung Yuen et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Quantitative Hepatitis B Surface Antigen Levels in Patients With Chronic Hepatitis B After 2 Years of Entecavir Treatment
- (2011) James Fung et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues
- (2011) Jerzy Jaroszewicz et al. ANTIVIRAL THERAPY
- Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir
- (2011) Jung Min Lee et al. HEPATOLOGY
- Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load
- (2011) Tai-Chung Tseng et al. HEPATOLOGY
- Serum HBsAg Decline During Long-term Potent Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B and Prediction of HBsAg Loss
- (2011) Roeland Zoutendijk et al. JOURNAL OF INFECTIOUS DISEASES
- Serum hepatitis B surface antigen monitoring in long-term lamivudine-treated hepatitis B virus patients
- (2011) A. Gramenzi et al. JOURNAL OF VIRAL HEPATITIS
- Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients
- (2011) R. Idilman et al. JOURNAL OF VIRAL HEPATITIS
- Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers
- (2010) Maurizia Rossana Brunetto et al. GASTROENTEROLOGY
- Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B
- (2010) E. Jenny Heathcote et al. GASTROENTEROLOGY
- A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B
- (2010) Henry Lik-Yuen Chan et al. HEPATOLOGY
- Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B*
- (2009) R. G. Gish et al. JOURNAL OF VIRAL HEPATITIS
- Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients
- (2008) Rami Moucari et al. HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started